Evidence map›Paper›PMID 33800535›Full record

ArticleCells2021

Novel Technique for Retinal Nerve Cell Regeneration with Electrophysiological Functions Using Human Iris-Derived iPS Cells.

Naoki Yamamoto, Noriko Hiramatsu, Mahito Ohkuma, Natsuko Hatsusaka, Shun Takeda, Noriaki Nagai, Ei-Ichi Miyachi, Masashi Kondo, Kazuyoshi Imaizumi, Masayuki Horiguchi and 2 more

Open access · goldAbstract read
In one paragraph

Article in Cells, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.5field-weighted citation impact, top 39% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 4 institutions in 1 country.

Naoki YamamotoDepartment of Ophthalmology, Kanazawa Medical University, Ishikawa 920-0293, Japan.ORCID 0000-0002-9659-3204
Noriko HiramatsuResearch Promotion and Support Headquarters, Fujita Health University, Aichi 470-1192, Japan.
Mahito OhkumaDepartment of Physiology, School of Medicine, Fujita Health University, Aichi 470-1192, Japan.
Natsuko HatsusakaDepartment of Ophthalmology, Kanazawa Medical University, Ishikawa 920-0293, Japan.
Shun TakedaDepartment of Ophthalmology, Kanazawa Medical University, Ishikawa 920-0293, Japan.
Noriaki NagaiFaculty of Pharmacy, Kindai University, Osaka 577-8502, Japan.
Ei-Ichi MiyachiDepartment of Physiology, School of Medicine, Fujita Health University, Aichi 470-1192, Japan.ORCID 0000-0001-9044-4884
Masashi KondoDepartment of Respiratory Medicine, School of Medicine, Fujita Health University, Aichi 470-1192, Japan.
Kazuyoshi ImaizumiDepartment of Respiratory Medicine, School of Medicine, Fujita Health University, Aichi 470-1192, Japan.
Masayuki HoriguchiDepartment of Ophthalmology, School of Medicine, Fujita Health University, Aichi 470-1192, Japan.
Eri KuboDepartment of Ophthalmology, Kanazawa Medical University, Ishikawa 920-0293, Japan.ORCID 0000-0001-6789-9311
Hiroshi SasakiDepartment of Ophthalmology, Kanazawa Medical University, Ishikawa 920-0293, Japan.
Fujita Health University · JPKanazawa Medical University · JPKindai University · JPNagoya Women's University · JP

Funding

Japan Society for the Promotion of Science 26462701, 17K11495, 20K09838, and 20K09815
6 · The paper itself

Abstract

Regenerative medicine in ophthalmology that uses induced pluripotent stem cells (iPS) cells has been described, but those studies used iPS cells derived from fibroblasts. Here, we generated iPS cells derived from iris cells that develop from the same inner layer of the optic cup as the retina, to regenerate retinal nerves. We first identified cells positive for p75NTR, a marker of retinal tissue stem and progenitor cells, in human iris tissue. We then reprogrammed the cultured p75NTR-positive iris tissue stem/progenitor (H-iris stem/progenitor) cells to create iris-derived iPS (H-iris iPS) cells for the first time. These cells were positive for iPS cell markers and showed pluripotency to differentiate into three germ layers. When H-iris iPS cells were pre-differentiated into neural stem/progenitor cells, not all cells became positive for neural stem/progenitor and nerve cell markers. When these cells were pre-differentiated into neural stem/progenitor cells, sorted with p75NTR, and used as a medium for differentiating into retinal nerve cells, the cells differentiated into Recoverin-positive cells with electrophysiological functions. In a different medium, H-iris iPS cells differentiated into retinal ganglion cell marker-positive cells with electrophysiological functions. This is the first demonstration of H-iris iPS cells differentiating into retinal neurons that function physiologically as neurons.

Indexed as

Electrophysiological PhenomenaCell DifferentiationCells, CulturedCellular ReprogrammingEmbryoid BodiesEmbryonic Stem CellsHumansInduced Pluripotent Stem CellsIrisNerve RegenerationNerve Tissue ProteinsReceptors, Nerve Growth FactorRecoverinReproducibility of ResultsRetinal Ganglion CellsRetinal NeuronsNerve Tissue ProteinsNGFR protein, humanRCVRN protein, humanReceptors, Nerve Growth FactorRecoverinelectrophysiologyhuman iris-derived iPS cellshuman iris tissue stem/progenitor cellsp75NTRrecoverinretinal ganglion cell

Identifiers

PMID33800535
PMCPMC8067101
OpenAlexW3142292593

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.